AMANDA EVANS: Open Payments
NPI 1699242545 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,417 in 80 payments from 13 companies in 2025. Trend: 2023 $1,451 · 2024 $1,660 · 2025 $1,417
Food & beverage: $1,303Education: $114
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $347 |
| Amgen Inc. | 21 | $180 |
| GlaxoSmithKline, LLC. | 9 | $164 |
| AstraZeneca Pharmaceuticals LP | 8 | $152 |
| PFIZER INC. | 6 | $106 |
| ABBVIE INC. | 5 | $101 |
| UCB, Inc. | 4 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
| GENZYME CORPORATION | 2 | $42 |
Products named: TREMFYA, BENLYSTA, SAPHNELO, XELJANZ, RINVOQ, Bimzelx, ORENCIA, EVENITY.
Industry payments across KY — which companies pay providers there.
